β2-glycoprotein I and annexin A5 phospholipid interactions: Artificial and cell membranes

Future alternative therapies of antiphospholipid syndrome are proposed to be based on the expanding knowledge of β2-GPI- and AnxA5-phospholipid interactions, specifically antagonizing β2-GPI receptors, as well as inhibiting their signaling pathways.